ALLEGRA HIVES DIN 02521245
Health Canada record
| Active ingredient(s) | FEXOFENADINE HYDROCHLORIDE 60 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | R06AX26 FEXOFENADINE |
| Original market date | 19-Jan-2023 |
| Current status date | 19-Jan-2023 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FEXOFENADINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02231462 | ALLEGRA 12 HOUR | SANOFI CONSUMER HEALTH INC | Tablet | FEXOFENADINE HYDROCHLORIDE 60 MG | Marketed |
| 02242819 | ALLEGRA 24 HOUR | SANOFI CONSUMER HEALTH INC | Tablet | FEXOFENADINE HYDROCHLORIDE 120 MG | Marketed |
| 02239853 | ALLEGRA-D | SANOFI CONSUMER HEALTH INC | Tablet (Immediate- And Extended-Release) | FEXOFENADINE HYDROCHLORIDE 60 MG; PSEUDOEPHEDRINE HYDROCHLORIDE 120 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 26868 | 2021-10-18 | Supplement to a New Drug Submission (SNDS) | NEW PRODUCT DIN. UPDATES TO THE PRODUCT MONOGRAPH |
International API supply for FEXOFENADINE HYDROCHLORIDE
7 valid EDQM Certificates of Suitability from 7 holders. 16 active FDA Drug Master Files.
Request a quote for ALLEGRA HIVES